Oxygen Biotherapeutics, Inc. (OXBO.OB) Files Patent Application for Emergency Heart Attack Treatment Device
Oxygen Biotherapeutics Inc. today announced that the company has submitted a patent application for a new invention that uses Oxycyte perfluorocarbon to deliver oxygen as a first aid treatment for victims of heart attack and strokes. Oxycyte is the company's perfluorocarbon (PFC) therapeutic oxygen carrier. The company's invention, called Vitavent, provides an immediate supply of Oxycyte and oxygen to the victim of a heart attack or stroke until medical help is available. It may be used easily by a victim of a heart attack or stroke, who is still conscious, without the assistance of another. It also may be used…